A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide (Q63253490)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 June 2006

Language	Label	Description	Also known as
English	A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide	scientific article published on 27 June 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

A conjugate vaccine composed of a heat shock protein 60 T-cell epitope peptide (p458) and Neisseria meningitidis type B capsular polysaccharide (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

based on heuristic

inferred from title

Neisseria meningitidis

1 reference

based on heuristic

inferred from title

María E Sarmiento

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

6

object named as

Irun R Cohen

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

author name string

Hila Amir-Kroll

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Luis Riveron

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Gustavo Sierra

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

language of work or name

0 references

publication date

27 June 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

42-43

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

6555-6563

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Towards a comprehensive view of immunoglobulin class switching

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Conjugate vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Glycoprotein conjugate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Planning, registration, and implementation of an immunisation campaign against meningococcal serogroup C disease in the UK: a success story

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Conjugates and reverse vaccinology to eliminate bacterial meningitis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Antigenic similarities between brain components and bacteria causing meningitis. Implications for vaccine development and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

An integrated molecular and immunological approach towards a meningococcal group B vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Immunogenicity of a serogroup B meningococcal vaccine against multiple Neisseria meningitidis strains in infants.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

The WHO Vaccine Trial Registry

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Immunogenicity of two efficacious outer membrane protein-based serogroup B meningococcal vaccines among young adults in Iceland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Toll-like receptors and their role in experimental models of microbial infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Inflammation activates self hsp60-specific T cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Proteins and their derived peptides as carriers in a conjugate vaccine for Streptococcus pneumoniae: self-heat shock protein 60 and tetanus toxoid

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Self heat-shock protein (hsp60) peptide serves in a conjugate vaccine against a lethal pneumococcal infection.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Self HSP60 peptide serves as an immunogenic carrier for a CTL epitope against persistence of murine cytomegalovirus in the salivary gland

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Mucosal vaccination against serogroup B meningococci: induction of bactericidal antibodies and cellular immunity following intranasal immunization with NadA of Neisseria meningitidis and mutants of Escherichia coli heat-labile enterotoxin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Ability of 3 different meningococcal C conjugate vaccines to induce immunologic memory after a single dose in UK toddlers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Serologic correlates of protection for evaluating the response to meningococcal vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Antibodies to polysialic acid and its N-propyl derivative: binding properties and interaction with human embryonal brain glycopeptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Crystallization and preliminary X-ray diffraction analysis of antigen-binding fragments which are specific for antigenic conformations of sialic acid homopolymers

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Immunogenicity of meningococcal B polysaccharide conjugated to tetanus toxoid or CRM197 via adipic acid dihydrazide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Preclinical evaluation of a novel group B meningococcal conjugate vaccine that elicits bactericidal activity in both mice and nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Characterization of Polysaccharide Conformational Epitopes by Surface Plasmon Resonance

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Absence of lipopolysaccharide high-dose paralysis in B-cell responses: Implications for the one-signal theory

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Innate immunity: the virtues of a nonclonal system of recognition

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Induction of Salmonella stress proteins upon infection of macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Heat-shock proteins and the host-pathogen interaction during bacterial infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Efficacy of a pneumococcal conjugate vaccine against acute otitis media

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Selections from current literature. Recent advances in conjugated pneumococcal vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Pneumococcal vaccines: do they prevent infection and how?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Antibodies to poly[(2----8)-alpha-N-acetylneuraminic acid] and poly[(2----9)-alpha-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

New carriers and adjuvants in the development of vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Effect of conjugation methodology, carrier protein, and adjuvants on the immune response to Staphylococcus aureus capsular polysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Linear PADRE T helper epitope and carbohydrate B cell epitope conjugates induce specific high titer IgG antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

DNA vaccination with heat shock protein 60 inhibits cyclophosphamide-accelerated diabetes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

DNA Fragments of the Human 60-kDa Heat Shock Protein (HSP60) Vaccinate Against Adjuvant Arthritis: Identification of a Regulatory HSP60 Peptide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Highly autoproliferative T cells specific for 60-kDa heat shock protein produce IL-4/IL-10 and IFN-gamma and are protective in adjuvant arthritis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Autoimmunity, microbial immunity and the immunological homunculus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

High frequency of cord blood lymphocytes against mycobacterial 65-kDa heat-shock protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Current concepts on Escherichia coli K1 translocation of the blood-brain barrier

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Passive transfer of meningococcal group B polysaccharide antibodies to the offspring of pregnant rabbits and their protective role against infection with Escherichia coli K1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Clinical evaluation of a group B meningococcal N-propionylated polysaccharide conjugate vaccine in adult, male volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Safety of vaccines containing meningococcal group B polysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Re-expression of PSA-NCAM by demyelinated axons: an inhibitor of remyelination in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Poly (alpha 2,8-deaminoneuraminic acid) is expressed in lung on a single 150-kDa glycoprotein and is an oncodevelopmental antigen

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Polysialic acid of the neural cell adhesion molecule in the human thyroid: a marker for medullary thyroid carcinoma and primary C-cell hyperplasia. An immunohistochemical study on 79 thyroid lesions

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Collective cell migration in morphogenesis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

Intranasal administration of a meningococcal outer membrane vesicle vaccine induces persistent local mucosal antibodies and serum antibodies with strong bactericidal activity in humans.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine monoclonal antibodies for detection of antigens and culture identification of Neisseria meningitidis group B and Escherichia coli K-1.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Dynamics of the murine humoral immune response to Neisseria meningitis group B capsular polysaccharide.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.06.019

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2006.06.019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16843573%20AND%20SRC:MED&resulttype=core&format=json

27 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q63253490&oldid=2140223056"